Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ansell

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Thrombosis Research|August 2, 2005
Effects of dietary supplements on hemostasisJ Ansell
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Factor Xa or thrombin: is factor Xa a better target?J Ansell
The American Journal of Cardiology|August 25, 2001
Developing a clinical strategy for cholesterol management in an era of unanswered questionsB J Ansell
Lancet (London, England)|November 15, 1975
Letter: Milk for babiesC J Ansell
American Family Physician|March 20, 2002
Improvement in current approaches to lipid loweringBenjamin J Ansell
Current Atherosclerosis Reports|February 3, 2005
Rationale for combination therapy with statin drugs in the treatment of dyslipidemiaBenjamin J Ansell
American Journal of Hypertension|October 26, 2005
Evidence for a combined approach to the management of hypertension and dyslipidemiaBenjamin J Ansell
Current Atherosclerosis Reports|December 17, 2008
A review of trials evaluating nonstatin lipid-lowering therapiesBenjamin J Ansell
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 20, 2004
Molecularly imprinted polymers in pseudoimmunoassayRichard J Ansell
The American Journal of Cardiology|December 6, 2007
Targeting the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Thrombosis Research|August 2, 2005
Effects of dietary supplements on hemostasisJ Ansell
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Factor Xa or thrombin: is factor Xa a better target?J Ansell
The American Journal of Cardiology|August 25, 2001
Developing a clinical strategy for cholesterol management in an era of unanswered questionsB J Ansell
Lancet (London, England)|November 15, 1975
Letter: Milk for babiesC J Ansell
American Family Physician|March 20, 2002
Improvement in current approaches to lipid loweringBenjamin J Ansell
Current Atherosclerosis Reports|February 3, 2005
Rationale for combination therapy with statin drugs in the treatment of dyslipidemiaBenjamin J Ansell
American Journal of Hypertension|October 26, 2005
Evidence for a combined approach to the management of hypertension and dyslipidemiaBenjamin J Ansell
Current Atherosclerosis Reports|December 17, 2008
A review of trials evaluating nonstatin lipid-lowering therapiesBenjamin J Ansell
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 20, 2004
Molecularly imprinted polymers in pseudoimmunoassayRichard J Ansell
The American Journal of Cardiology|December 6, 2007
Targeting the anti-inflammatory effects of high-density lipoproteinBenjamin J Ansell
Pageof 20